SG
StepStone Group’s Entrada Therapeutics TRDA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.12M | Hold |
761,277
| – | – | 10.14% | 4 |
|
|
2025
Q1 | $6.88M | Hold |
761,277
| – | – | 7.07% | 4 |
|
|
2024
Q4 | $13.2M | Hold |
761,277
| – | – | 11.51% | 3 |
|
|
2024
Q3 | $12.2M | Hold |
761,277
| – | – | 4.44% | 7 |
|
|
2024
Q2 | $10.8M | Hold |
761,277
| – | – | 2.2% | 8 |
|
|
2024
Q1 | $10.8M | Hold |
761,277
| – | – | 2.29% | 8 |
|
|
2023
Q4 | $11.5M | Hold |
761,277
| – | – | 2.07% | 8 |
|
|
2023
Q3 | $12M | Hold |
761,277
| – | – | 2.68% | 7 |
|
|
2023
Q2 | $11.5M | Hold |
761,277
| – | – | 2.13% | 7 |
|
|
2023
Q1 | $11M | Hold |
761,277
| – | – | 2.05% | 7 |
|
|
2022
Q4 | $10.3M | Hold |
761,277
| – | – | 1.34% | 12 |
|
|
2022
Q3 | $12M | Buy |
761,277
+126,318
| +20% | +$1.99M | 1.71% | 10 |
|
|
2022
Q2 | $7.73M | Sell |
634,959
-126,318
| -17% | -$1.54M | 0.83% | 15 |
|
|
2022
Q1 | $7.15M | Hold |
761,277
| – | – | 0.53% | 14 |
|
|
2021
Q4 | $13M | Buy |
+761,277
| New | +$13M | 0.74% | 13 |
|